Detalhe da pesquisa
1.
TRAF4 promotes TGF-ß receptor signaling and drives breast cancer metastasis.
Mol Cell
; 51(5): 559-72, 2013 Sep 12.
Artigo
Inglês
| MEDLINE | ID: mdl-23973329
2.
The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients.
Int J Cancer
; 143(12): 3194-3200, 2018 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29978463
3.
Alternatively spliced tissue factor promotes breast cancer growth in a ß1 integrin-dependent manner.
Proc Natl Acad Sci U S A
; 110(28): 11517-22, 2013 Jul 09.
Artigo
Inglês
| MEDLINE | ID: mdl-23801760
4.
High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients.
BMC Cancer
; 14: 604, 2014 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-25139823
5.
Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patients.
Breast Cancer Res Treat
; 142(2): 355-64, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24197659
6.
The prognostic value of apoptotic and proliferative markers in breast cancer.
Breast Cancer Res Treat
; 142(2): 323-39, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24194179
7.
Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer.
Breast Cancer Res Treat
; 131(3): 859-69, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-21479925
8.
Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.
Breast Cancer Res Treat
; 133(1): 49-59, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21796367
9.
Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study.
Breast Cancer Res Treat
; 134(3): 1103-14, 2012 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-22476853
10.
Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer.
BMC Cancer
; 12: 42, 2012 Jan 26.
Artigo
Inglês
| MEDLINE | ID: mdl-22280212
11.
NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study.
BMC Cancer
; 12: 24, 2012 Jan 18.
Artigo
Inglês
| MEDLINE | ID: mdl-22257486
12.
HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients.
J Immunol
; 185(12): 7452-9, 2010 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21057081
13.
Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10.
Breast Cancer Res
; 13(4): R72, 2011 Jul 18.
Artigo
Inglês
| MEDLINE | ID: mdl-21767389
14.
COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients.
Breast Cancer Res Treat
; 125(3): 671-85, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-20358279
15.
Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients.
Breast Cancer Res Treat
; 125(3): 687-96, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-20361254
16.
Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients.
Mol Oncol
; 8(5): 1014-25, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24767310
17.
The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer.
Clin Cancer Res
; 16(4): 1272-80, 2010 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20145162